HOME>Most Read

China progresses in hepatitis B vaccination, more treatment effort urged

english.news.cn    2015-07-28 09:48:00    

  BEIJING, July 24 (Xinhua) -- China has won praises from WHO after reaching its goal to control hepatitis B infection among children through immunization ahead of schedule, but more effort is urged for its adult patients.

  The National Health and Family Planning Commission announced on Friday that the prevalence of hepatitis B surface antigen, a key index indicating hepatitis B virus (HBV) infection, for Chinese children in the 1-4 and 5-14 age groups both decreased by more than 60 percent from 2006 to 0.32 and 0.94 percent respectively.

  This means the country has reached the goal set by the WHO to reduce HBV infection prevalence in children to less than one percent ahead of the deadline of 2017, making the current generation of children the first in the country's history to be almost hepatitis B-free.

  Viral hepatitis is a severe health threat and the leading cause of cirrhosis of the liver and liver cancer. China has about 90 million people living with chronic hepatitis B. China started its hepatitis B vaccination program in 1992, focusing on children under 15.

  "Slashing the rate of hepatitis B infection in children means China has drastically reduced this generation's chances of developing conditions like cirrhosis of the liver and liver cancer later in life. This is an extraordinary public health success story," said WHO China Representative Bernhard Schwartlander on Friday.

  Meanwhile, Jia Jidong, a hepatopathy expert with the Beijing Friendship Hospital under the Capital Medical University, noted a large number of Chinese adults are infected by hepatitis B, citing problems including inconsistent treatments and high medicine cost.

  "Many adult patients were not able to follow through long-term use of high-end drugs due to various reasons, which held back treatment," Jia said, adding that the country's hepatitis B prevention and control task is arduous.

  Dr Schwartlander also called for "the same determined, evidence-based, public health approach which created China's highly successful hepatitis B vaccination program" to be adopted for the treatments of the country's adult patients".

 

Editor:Yu Liang

网站地图 申博太阳城直营网 申博登入网址 777老虎机游戏登入 ag娱乐登入
太阳城申博代理加盟 太阳城开户信誉最好 正规太阳城申博开户登入 申博太阳城亚洲微信支付充值
现金网百家乐 申博手机下载版 申博网址 幸运大转盘
申博太阳城注册 申博代理 ag真人百家乐 太阳城网址
申博百家乐 老虎机游戏 太阳城代理 真人百家乐